Effect of dextrose prolotherapy on internal derangement of the temporomandibular joint

被引:0
作者
Mohammed, M. R. [1 ]
Hamad, S. A. [2 ]
Al-Daeoody, A. D. [3 ]
Shehab, A. A. [4 ]
Ahmed, O. S. [4 ]
机构
[1] Erbil Polytech Univ, Dept Dent Assistant, Med Inst, Erbil, Kurdistan, Iraq
[2] Kurdistan Higher Council Med Specialties, Erbil, Kurdistan, Iraq
[3] Al Manara Coll Med Sci, Dept Dent, Mysan, Iraq
[4] Carol Davila Univ Med & Pharm, Bucharest, Romania
关键词
Dextrose; Internal derangement; Pain; Prolothera; py; Temporomandibular joint; ACUTE TOXICITY EVALUATION; HYPERMOBILITY; DISORDERS; PLACEBO; PROLIFEROL; SPLINTS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: This study aimed to evaluate the effect of dextrose prolotherapy in treating internal derangement of the temporomandibular joint.PATIENTS AND METHODS: A total of 20 patients with temporomandibular joint internal derangement were enrolled in the study. The diagnosis of internal derangement was confirmed by magnetic resonance imaging (MRI). The posterior and anterior disc attachment, as well as the most tender part of the masseter muscle, were injected with 12.5% dextrose. Pain, maximum mouth opening, clicking, and deviation were assessed immediately before treatment, as well as at 2-, 4-, and 12- weeks post-treatment. RESULTS: There was a significant improvement in the four clinical variables at the threetime intervals. Pain at two weeks was reduced by 60% (6 vs. 3.75) and by 200% (6 vs. 1.9) at 4 weeks. The maximum mouth opening was increased by 6.4 mm at 2 weeks and 7.85 mm at 4 weeks. The percentage of patients with clicking decreased from 70%, preoperatively- to 50% at 2 weeks, 15% at 4 weeks, and 5% at 12 weeks. The ratio of patients with deviation was decreased from 80% preoperatively to 35% at 2 weeks, 15% at 4 weeks, and 5% at 12 weeks.CONCLUSIONS: Prolotherapy is a safe and effective treatment for alleviating the symptoms of internal derangement of the temporomandibular joint.
引用
收藏
页码:4883 / 4889
页数:7
相关论文
共 29 条
[1]   Non-invasive different modalities of treatment for temporomandibular disorders: review of literature [J].
Abouelhuda, Amira Mokhtar ;
Khalifa, Ahmad Khalifa ;
Kim, Young-Kyun ;
Hegazy, Salah Abdelftah .
JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2018, 44 (02) :43-51
[2]  
Adina S, 2020, J BIOL REG HOMEOS AG, V34, P747, DOI 10.23812/20-204-E-52
[3]   Acute toxicity evaluation of proliferol: A dose-escalating, placebo-controlled study in rats [J].
Dagenais, Simon ;
Mayer, John ;
Wooley, James R. ;
Haldeman, Scott ;
Hite, Mark .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2007, 26 (05) :451-463
[4]   Acute Toxicity Evaluation of Proliferol: A Dose-Escalating, Placebo-Controlled Study in Swine [J].
Dagenais, Simon ;
Wooley, James ;
Hite, Mark ;
Green, Robert ;
Mayer, John .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2009, 28 (03) :219-229
[5]   Impact of prolotherapy in temporomandibular joint disorder: a quality of life assessment [J].
Dasukil, S. ;
Arora, G. ;
Shetty, S. ;
Degala, S. .
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2021, 59 (05) :599-604
[6]   Efficacy of Prolotherapy in Temporomandibular Joint Disorders: An Exploratory Study [J].
Dasukil, Saubhik ;
Shetty, Sujeeth Kumar ;
Arora, Geetanjali ;
Degala, Saikrishna .
JOURNAL OF MAXILLOFACIAL & ORAL SURGERY, 2021, 20 (01) :115-120
[7]  
de Leeuw Reny, 2008, Oral Maxillofac Surg Clin North Am, V20, P159, DOI 10.1016/j.coms.2007.12.004
[8]   3-DIMENSIONAL VISUALIZATION OF THE TEMPOROMANDIBULAR-JOINT - A COMPUTERIZED MULTISECTIONAL AUTOPSY STUDY OF DISK POSITION AND CONFIGURATION [J].
DIJKGRAAF, LC ;
DEBONT, LGM ;
OTTEN, E ;
BOERING, G .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1992, 50 (01) :2-10
[9]   Prolotherapy (Proliferation therapy) in the treatment of TMD [J].
Hakala, RV .
CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2005, 23 (04) :283-288
[10]  
Hauser RA, 2007, Practical Pain Management, V7, P49